title: Systematic Review of Observational Studies and Rcts of Omalizumab in Severe Persistent Allergic Asthma and Meta-Analysis Feasibility Assessment.
authors.affiliation: Mapi, Inc., Boston, MA, USA.
authors.forename: E
authors.initials: E
authors.lastname: Bergrath
authors.affiliation: Novartis Pharma AG, Basel, Switzerland.
authors.forename: S
authors.initials: S
authors.lastname: Hwa Ong
authors.affiliation: University of Montpellier, Montpellier, France.
authors.forename: J
authors.initials: J
authors.lastname: Bousquet
authors.affiliation: Novartis Pharma AG (Employed by Novartis at time of systematic literature review), Basel, Switzerland.
authors.forename: M
authors.initials: M
authors.lastname: Balwin
authors.affiliation: Novartis Pharma AG, Basel, Switzerland.
authors.forename: V
authors.initials: V
authors.lastname: Manga
authors.affiliation: Novartis Pharma AG, Basel, Switzerland.
authors.forename: S
authors.initials: S
authors.lastname: Rao
authors.affiliation: Mapi, Toronto, ON, Canada.
authors.forename: S
authors.initials: S
authors.lastname: Cope